Problem statement: Answer the MCQ question.
Question: Which compound exhibits a -18.257% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a. Cc1cc(Nc2cccc(C)c2C)n2nc(C)nc2n1
b. COc1cc(C(c2oc(CO)cc(=O)c2O)c2oc(CO)cc(=O)c2O)cc(OC)c1OC
c. Nc1nc(=S)n(-c2ccccc2)[nH]1
d. CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(NCC3CCCO3)c2)CC1
e. COc1ccccc1N(C)S(=O)(=O)c1ccc(Cl)c(C(=O)NCCCN2CCOCC2)c1
Answer: d. CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(NCC3CCCO3)c2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(NCC3CCCO3)c2)CC1
CC(=O)N1CCN(c2ccc([N+](=O)[O-])c(NCC3CCCO3)c2)CC1
1-[4-[4-nitro-3-(oxolan-2-ylmethylamino)phenyl]piperazin-1-yl]ethanone